Alzheimer's Disease Trial, Recruiting (NCT07486037)

Alzheimer's Disease Trial, Recruiting NCT07486037 Sponsor: Indiana University Condition: Alzheimer's Disease

Printed from Voxsanity (voxsanity.com.au) — NCT07486037 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Alzheimers Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who identify as African American
People who are 18 years of age or older
People who are the main unpaid caregiver for an adult living with Alzheimer's disease or a related form of dementia
People who can read and speak English
People who a health screening questionnaire (called the PAR-Q+) determines are healthy enough to take part in exercise
People who have access to an email address

Who may not be able to join:

People who have been diagnosed with a psychiatric illness
People who have severe major depression that is not currently being treated
People who are currently receiving advanced cancer treatment or hospice care
People who are currently receiving dialysis
People who have severe hearing loss and do not use hearing aids
People who have severe vision impairment and do not use corrective eyeglasses
People who do not have access to a phone or email
People who the PAR-Q+ health screening questionnaire determines cannot safely exercise
People who are already meeting the recommended physical activity guidelines at the time of enrollment

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 317 278-9598

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07486037

Sponsor: Indiana University

Phase: Not Applicable

Status: Recruiting

Condition: Alzheimer's Disease

Trial contact: 317 278-9598

More information: https://clinicaltrials.gov/study/NCT07486037

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who identify as African American
People who are 18 years of age or older
People who are the main unpaid caregiver for an adult living with Alzheimer's disease or a related form of dementia
People who can read and speak English
People who a health screening questionnaire (called the PAR-Q+) determines are healthy enough to take part in exercise
People who have access to an email address

Who may not be able to join:

People who have been diagnosed with a psychiatric illness
People who have severe major depression that is not currently being treated
People who are currently receiving advanced cancer treatment or hospice care
People who are currently receiving dialysis
People who have severe hearing loss and do not use hearing aids
People who have severe vision impairment and do not use corrective eyeglasses
People who do not have access to a phone or email
People who the PAR-Q+ health screening questionnaire determines cannot safely exercise
People who are already meeting the recommended physical activity guidelines at the time of enrollment

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Indiana University

Registry

ClinicalTrials.gov

Start date

1 March 2026

Est. completion

1 May 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Physical Activity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov